Plain-English translation of NCT06593080 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The DECIDE-TB trial is testing a new, structured approach to help doctors and nurses screen, diagnose, and treat tuberculosis in children under 15 at district hospitals and health centers in Mozambique and Zambia. Right now, TB in children is often missed or diagnosed late because the methods vary from place to place. This trial will check whether using the same, clear step-by-step decision tools — including blood tests, breathing samples, and chest X-rays where needed — helps find more children with TB earlier and gets them the right treatment faster.
Tuberculosis in children is a serious problem in Africa, but it is often overlooked or diagnosed too late because health facilities use different approaches. This trial wants to see if giving all clinics and hospitals a common, proven set of diagnostic steps can catch more TB cases in children and make sure every child gets treated quickly and correctly.
You likely qualify if…
You likely don't qualify if…
If your child is seen at a participating health facility and shows signs of possible TB, they will be offered the new diagnostic pathway, which may include TB screening questions, HIV testing, a test on a sputum or stool sample, a tuberculin skin test, urine testing, and a chest X-ray if needed. The health workers will use digital tools and clear decision steps to help decide whether your child has TB and what treatment they need. The trial will track how well this new approach works, how easy it is to use, what it costs, and whether families and health workers find it helpful and acceptable.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Zambia